CN102772384A — 一种盐酸米诺环素缓释片及其制备方法
Assigned to Sichuan Baili Pharmaceutical Co Ltd · Expires 2012-11-14 · 14y expired
What this patent protects
本发明公开了一种盐酸米诺环素缓释片,由下述重量配比的组分构成:盐酸米诺环素40-90份、羟丙甲纤维素80-120份、乳糖200-260份、二氧化硅3-8份、硬脂酸镁2-6份、包衣材料4-10份。本发明还公开了上述缓释片的制备方法。本发明盐酸米诺环缓释片减少了已知的米诺环素引起的急性前庭不良事件,药物释放稳定;制备方法构思巧妙、流程简单,工艺稳定,操作简便,生产周期短,提高了产品收率及产品稳定性,降低了生产成本。
USPTO Abstract
本发明公开了一种盐酸米诺环素缓释片,由下述重量配比的组分构成:盐酸米诺环素40-90份、羟丙甲纤维素80-120份、乳糖200-260份、二氧化硅3-8份、硬脂酸镁2-6份、包衣材料4-10份。本发明还公开了上述缓释片的制备方法。本发明盐酸米诺环缓释片减少了已知的米诺环素引起的急性前庭不良事件,药物释放稳定;制备方法构思巧妙、流程简单,工艺稳定,操作简便,生产周期短,提高了产品收率及产品稳定性,降低了生产成本。
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.